Lead-Plaintiff Deadline Hits in Perrigo Securities Suit Tied to Infant Formula Unit
The suit alleges Perrigo misled investors about problems in its Nestlé‑acquired infant formula business, with the case still at an initial procedural stage.
Overview
- Investors have until January 16, 2026 to ask the Southern District of New York to appoint them as lead plaintiff under the PSLRA process.
- The class action covers purchasers of Perrigo securities from February 27, 2023 through November 4, 2025.
- Complaints claim underinvestment and manufacturing deficiencies at the infant formula business required greater remediation spending than disclosed, overstating earnings and cash flow.
- Perrigo’s November 5, 2025 update cut its fiscal 2025 outlook, launched a strategic review of the infant formula unit, and reassessed a previously announced $240 million investment, after which shares fell 25.2% in one day.
- Multiple investor-rights firms, including Bragar Eagel & Squire, Levi & Korsinsky, and Rosen Law Firm, are soliciting affected shareholders, and no class has been certified with allegations unproven.